205 related articles for article (PubMed ID: 9191617)
1. Treatment of dysthymia.
Buni TM
J Fam Pract; 1997 Jun; 44(6):528-9. PubMed ID: 9191617
[No Abstract] [Full Text] [Related]
2. Sertraline and imipramine for the treatment of dysthymia.
de Jonghe F
Arch Gen Psychiatry; 1997 Oct; 54(10):973. PubMed ID: 9337782
[No Abstract] [Full Text] [Related]
3. Are there differences by gender in response to pharmacotherapy for depression?
Marsland TW; Newton W
J Fam Pract; 2000 Dec; 49(12):1149. PubMed ID: 11132066
[No Abstract] [Full Text] [Related]
4. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
Kocsis JH; Zisook S; Davidson J; Shelton R; Yonkers K; Hellerstein DJ; Rosenbaum J; Halbreich U
Am J Psychiatry; 1997 Mar; 154(3):390-5. PubMed ID: 9054788
[TBL] [Abstract][Full Text] [Related]
5. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Keller MB; Gelenberg AJ; Hirschfeld RM; Rush AJ; Thase ME; Kocsis JH; Markowitz JC; Fawcett JA; Koran LM; Klein DN; Russell JM; Kornstein SG; McCullough JP; Davis SM; Harrison WM
J Clin Psychiatry; 1998 Nov; 59(11):598-607. PubMed ID: 9862606
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
Hellerstein DJ; Kocsis JH; Chapman D; Stewart JW; Harrison W
Am J Psychiatry; 2000 Sep; 157(9):1436-44. PubMed ID: 10964860
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB
Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF
Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Lydiard RB; Stahl SM; Hertzman M; Harrison WM
J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
[TBL] [Abstract][Full Text] [Related]
11. [Drug of the month. Sertraline (Serlain)].
Scheen AJ
Rev Med Liege; 1994 Sep; 49(9):519-20. PubMed ID: 7939024
[No Abstract] [Full Text] [Related]
12. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial.
Forlenza OV; Almeida OP; Stoppe A; Hirata ES; Ferreira RCR
Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337
[TBL] [Abstract][Full Text] [Related]
13. The undertreatment of dysthymia.
Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.
Versiani M
J Affect Disord; 1998 Dec; 51(3):323-32. PubMed ID: 10333986
[TBL] [Abstract][Full Text] [Related]
15. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
Rush AJ; Koran LM; Keller MB; Markowitz JC; Harrison WM; Miceli RJ; Fawcett JA; Gelenberg AJ; Hirschfeld RM; Klein DN; Kocsis JH; McCullough JP; Schatzberg AF; Thase ME
J Clin Psychiatry; 1998 Nov; 59(11):589-97. PubMed ID: 9862605
[TBL] [Abstract][Full Text] [Related]
16. A novel placebo lead-in behavior strategy for sertraline dosing in a depressed patient highly sensitive to medication side effects.
Moss JH
J Clin Psychiatry; 1997 Sep; 58(9):405-6. PubMed ID: 9378695
[No Abstract] [Full Text] [Related]
17. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
Miller IW; Keitner GI; Schatzberg AF; Klein DN; Thase ME; Rush AJ; Markowitz JC; Schlager DS; Kornstein SG; Davis SM; Harrison WM; Keller MB
J Clin Psychiatry; 1998 Nov; 59(11):608-19. PubMed ID: 9862607
[TBL] [Abstract][Full Text] [Related]
18. Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
Bouwer C; Stein DJ
J Nerv Ment Dis; 1998 May; 186(5):316-8. PubMed ID: 9612450
[No Abstract] [Full Text] [Related]
19. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
Tignol J; Pujol-Domenech J; Chartres JP; Léger JM; Plétan Y; Tonelli I; Tournoux A; Pezous N
Acta Psychiatr Scand; 1998 Feb; 97(2):157-65. PubMed ID: 9517912
[TBL] [Abstract][Full Text] [Related]
20. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M
Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
